The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Chowdhury, Rasheduzzaman, Yeoh, Kar Kheng, Tian, Ya‐Min, Hillringhaus, Lars, Bagg, Eleanor A, Rose, Nathan R, Leung, Ivanhoe K H, Li, Xuan S +10 more·2011·The EMBO Reports

DOI 10.1038/embor.2011.43

Cited by (1,000)

Items 301–400 of 1,000

Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
Shuang Liu, Tom A.D. Cadoux-Hudson, Christopher John Schofield · 2020 · Current Opinion in Chemical Biology
Molecular mechanisms and therapeutic targets in pediatric brain tumors
Kun-Wei Liu, Kristian W. Pajtler, Barbara Christine Worst, Stefan Michael Pfister, Robert J. Wechsler‐Reya · 2017 · Science Signaling
Prognostic significance of concurrent gene mutations in intensively treated patients withIDH-mutated AML: an ALFA study
Matthieu Duchmann, Jean‐Baptiste Micol, Nicolas Duployez, Emmanuel Raffoux, Xavier Thomas, Jean‐Pierre Marolleau, Thorsten Braun, Lionel Adès, Sylvain Chantepie, Émilie Lemasle et al. · 2021 · Blood
Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death
Isabelle Vanessa Mohrenz, Patrick Antonietti, Stefan Pusch, David Capper, Jörg Balß, Sophia Voigt, Susanne Weißert, Alicia Mukrowsky, Jan Frank, Christian Senft et al. · 2013 · APOPTOSIS
Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
Federico Andreoli, Arménio Jorge Moura Barbosa, Marco Daniele Parenti, Alberto Del Río · 2012 · Current Pharmaceutical Design
Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy
Manabu Natsumeda, Hironaka Igarashi, Toshiharu Nomura, Ryosuke Ogura, Yoshihiro Tsukamoto, Tsutomu Kobayashi, Hiroshi Aoki, Kouichirou Okamoto, Akiyoshi Kakita, Hitoshi Takahashi et al. · 2014 · Acta Neuropathologica Communications
Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma
Adrián Mariño‐Enríquez, Judith V.M.G. Bovée · 2016 · Surgical pathology clinics
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence
Elena V. Efimova, Satoe Takahashi, Noumaan A. Shamsi, Ding Wu, Edwardine Labay, Olesya A. Ulanovskaya, Ralph R. Weichselbaum, Sergey A. Kozmin, Stephen J. Kron · 2015 · Molecular Cancer Research
Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
Dongki Yang, Jaehong Kim · 2019 · Cells
Mitochondrial Metabolism in Major Neurological Diseases
Zhengqiu Zhou, Grant L. Austin, Lyndsay E.A. Young, Lance A. Johnson, Ramon C. Sun · 2018 · Cells
Solid tumours hijack the histone variant network
Flávia G. Ghiraldini, Dan Filipescu, Emily Bernstein · 2021 · Nature reviews. Cancer
Kinetic Analysis of Iron-Dependent Histone Demethylases: α-Ketoglutarate Substrate Inhibition and Potential Relevance to the Regulation of Histone Demethylation in Cancer Cells
Barbara Cascella, Liviu M. Mirica · 2012 · Biochemistry
Recent advances in cancer metabolism: a technological perspective
Yun Pyo Kang, Nathan P. Ward, Gina M. DeNicola · 2018 · Experimental & Molecular Medicine
Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
Heng Zheng, Yan Tie, Zhen Ying Fang, Xiaoai Wu, Tao Yi, Shuang Huang, Xiao Liang, Yanping Qian, Xi Wang, Ruyu Pi et al. · 2019 · Signal Transduction and Targeted Therapy
IDH Mutations in Tumorigenesis and Their Potential Role As Novel Therapeutic Targets
Daniel Krell, Paul James Mulholland, Adam Enver Frampton, Jonathan Krell, Justin Stebbing, Chiara Bardella · 2013 · Future Oncology
Mitochondrial acetyl-CoA reversibly regulates locus-specific histone acetylation and gene expression
Oswaldo A. Lozoya, Tianyuan Wang, Dagoberto Grenet, Taylor C. Wolfgang, Mack Sobhany, Douglas Ganini da Silva, Gonzalo Riadi, Navdeep S. Chandel, Richard P. Woychik, Janine Hertzog Santos · 2019 · Life Science Alliance
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
Yang Liu, Fengchao Lang, Fu-Ju Chou, Kareem A. Zaghloul, Chunzhang Yang · 2020 · Biomedicines
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
Tesileanu, C. Mircea S., Vallentgoed, Wies R., Sanson, Marc, Taal, Walter, Clement, Paul M., Wick, Wolfgang, Brandes, Alba Ariela, Baurain, Jean Francais, Chinot, Olivier L., Wheeler, Helen et al. · 2021 · Acta Neuropathologica
Cancer-associated 2-oxoglutarate analogues modify histone methylation by inhibiting histone lysine demethylases
Tuomas Laukka, Matti Myllykoski, Ryan Looper, Peppi Koivunen · 2018 · Journal of Molecular Biology
Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs
Ammad Ahmad Farooqı, Sundas Fayyaz, Palmiro Poltronieri, George A. Călin, Massimo Mallardo · 2020 · Seminars in Cancer Biology
Current concepts in organic acidurias: understanding intra‐ and extracerebral disease manifestation
Stefan Kölker, Peter Burgard, Sven Wolfgang Sauer, Jürgen G. Okun · 2013 · Journal of Inherited Metabolic Disease
Reporter Ligand NMR Screening Method for 2-Oxoglutarate Oxygenase Inhibitors
Ivanhoe K. H. Leung, Marina Demetriades, A. Hardy, Clarisse Lejeune, Tristan J. Smart, Andrea Szöllössi, Akane Kawamura, Christopher John Schofield, Timothy D. W. Claridge · 2012 · Journal of Medicinal Chemistry
New Insights into Protein Hydroxylation and Its Important Role in Human Diseases
Giada Zurlo, Jianping Guo, Mamoru Takada, Wenyi Wei, Qing Hua Zhang · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia
Ogawara, Yoko, Katsumoto, Takuo, Aikawa, Yukiko, Shima, Yutaka, Kagiyama, Yuki, Soga, Tomoyoshi, Matsunaga, Hironori, Seki, Takahiko, Araki, Kazushi, Kitabayashi, Issay · 2015 · Cancer Research
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation
Nicholas T. Crump, Andreas V. Hadjinicolaou, Xia Meng, John Walsby-Tickle, Uzi Gileadi, Ji‐Li Chen, Mashiko Setshedi, Lars Rønn Olsen, I‐Jun Lau, Laura Godfrey et al. · 2021 · Cell Reports
SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors
Xiaomin Wang, Ziqi Chen, Jun Xu, Shuai Tang, Nan An, Lei Jiang, Yixiang Zhang, Shaoying Zhang, Qingli Zhang, Yanyan Shen et al. · 2022 · Cell Research
The role of mutations in epigenetic regulators in myeloid malignancies
Brittany A. Woods, Ross L. Levine · 2014 · Immunological Reviews
The small members of the JMJD protein family: Enzymatic jewels or jinxes?
Sangphil Oh, Sook Shin, Ralf Janknecht · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Glutarate regulates T cell metabolism and anti-tumour immunity
Eleanor Minogue, Pedro P. Cunha, Brennan J. Wadsworth, Guinevere L. Grice, Shiv K. Sah‐Teli, R. J. F. Hughes, David Bargiela, Alessandro Quaranta, Javier Zurita, Robin Antrobus et al. · 2023 · Nature Metabolism
Molecular markers of glioma: an update on recent progress and perspectives
Kirti Gupta, Pravin Salunke · 2012 · Journal of Cancer Research and Clinical Oncology
Histone 3 Lysine 9 Trimethylation Is Differentially Associated With Isocitrate Dehydrogenase Mutations in Oligodendrogliomas and High-Grade Astrocytomas
Sriram Venneti, Michelle Madden Felicella, Thomas M. Coyne, Joanna J. Phillips, Daniel J. Gorovets, Jason T. Huse, Julia Kofler, Chao Lü, Tarık Tihan, Lisa M. Sullivan et al. · 2013 · Journal of Neuropathology & Experimental Neurology
The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
Cara Reiter–Brennan, Lukas Semmler, Andreas Klein · 2018 · Współczesna Onkologia
A Potent Blood–Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model
Yukino Machida, Makoto Nakagawa, Hironori Matsunaga, Masayuki Yamaguchi, Yoko Ogawara, Yutaka Shima, Kazutsune Yamagata, Takuo Katsumoto, Ayuna Hattori, Masato Itoh et al. · 2019 · Molecular Cancer Therapeutics
Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins
Beatrice Parma, Heiko Wurdak, Paolo Ceppi · 2022 · Drug Resistance Updates
From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma
Gavin P. Dunn, Ovidiu C. Andronesi, Daniel P. Cahill · 2013 · Neurosurgical FOCUS
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
Elisabet Cuyàs, Salvador Fernández‐Arroyo, Bruna Corominas-Faja, Esther Rodríguez‐Gallego, Joaquim Bosch‐Barrera, Begoña Martı́n-Castillo, Rafel Llorens, Jorge Joven, Javier Abel Menéndez · 2015 · Oncotarget
Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency
Diego Avellaneda Matteo, Adam J. Grunseth, Eric R. Gonzalez, Stacy L. Anselmo, Madison Arza Kennedy, Precious Moman, David A. Scott, An D. Hoang, Christal Dyane Sohl · 2017 · Journal of Biological Chemistry
Mitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions
Bargiela, David, Burr, Stephen P., Chinnery, Patrick F. · 2018 · Trends in Endocrinology & Metabolism
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Anna Maria Reuss, Dominik Groos, Michael Buchfelder, Nicolai E. Savaskan · 2021 · International Journal of Molecular Sciences
5-Hydroxymethylcytosine Profiling as an Indicator of Cellular State
Alexander Laird, John P. Thomson, David James Harrison, Richard R. Meehan · 2013 · Epigenomics
Metabolic intermediates – Cellular messengers talking to chromatin modifiers
Anna Nieborak, Robert Schneider · 2018 · Molecular Metabolism
Demethylation of the Protein Phosphatase PP2A Promotes Demethylation of Histones to Enable Their Function as a Methyl Group Sink
Cunqi Ye, Benjamin M. Sutter, Yun Wang, Zheng Kuang, Xiaozheng Zhao, Yonghao Yu, Benjamin P. Tu · 2019 · Molecular Cell
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas
Victor Ruiz‐Rodado, Tathiane Maistro Malta, Tomohiro Seki, Adrian Lita, Tyrone Dowdy, Orieta Celiku, Alejandra Cavazos Saldana, Aiguo Li, Yang Liu, Sue Han et al. · 2019 · Neuro-Oncology
Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
Ingvild Comfort Hvinden, Tom A.D. Cadoux-Hudson, Christopher John Schofield, James McCullagh · 2021 · Cell Reports Medicine
Metabolic reprogramming of pulmonary fibrosis
Jiaxin Li, Xiaoxuan Zhai, Xiao Sun, Shengchuan Cao, Qiuhuan Yuan, Jiali Wang · 2022 · Frontiers in Pharmacology
Mutant IDH in Gliomas: Role in Cancer and Treatment Options
Georgios Solomou, Alina Finch, Asim Asghar, Chiara Bardella · 2023 · Cancers
Metabolic Modulation of Epigenetics in Gliomas
Sriram Venneti, Craig B. Thompson · 2013 · Brain Pathology
D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth
Shenghong Ma, Bowen Jiang, Wanglong Deng, Zhong-Kai Gu, Fei-Zhen Wu, Tingting Li, Yukun Xia, Hui Yang, Dan Ye, Yue Xiong et al. · 2015 · Oncotarget
Redox regulation of the epigenetic landscape in Cancer: A role for metabolic reprogramming in remodeling the epigenome
Michael James Hitchler, Frederick E. Domann · 2012 · Free Radical Biology and Medicine
Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
Anna Eriksson, Andreas Lennartsson, Sören Lehmann · 2015 · Experimental Hematology
Targeting Metabolic Changes in Cancer: Novel Therapeutic Approaches
Ekaterina V. Bobrovnikova-Marjon, Jonathan Hurov · 2014 · Annual Review of Medicine
Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1α in lipopolysaccharide-activated macrophages
Niamh C. Williams, Dylan G. Ryan, Ana S.H. Costa, Evanna L. Mills, Mark P. Jedrychowski, Suzanne M. Cloonan, Christian Frezza, Luke A.J. O'Neill · 2021 · Journal of Biological Chemistry
Mitochondria–actin cytoskeleton crosstalk in cell migration
Tarun Yadav, David M. Gau, Partha Sarathi Roy · 2022 · Journal of Cellular Physiology
Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors
Michael R. Drumm, Wenxia Wang, Thomas K. Sears, Kirsten B. Burdett, Rodrigo A. Javier, Kristen Y. Cotton, Brynna Webb, Kayla Byrne, Dusten J. Unruh, Vineeth M. Thirunavu et al. · 2023 · Journal of Clinical Investigation
Metabolic circuits in neural stem cells
Do‐Yeon Kim, Inmoo Rhee, Jihye Paik · 2014 · Cellular and Molecular Life Sciences
A mechanistic overview of TET-mediated 5-methylcytosine oxidation
V. K. Chaithanya Ponnaluri, Jaroslaw Pawel Maciejewski, Mridul Mukherji · 2013 · Biochemical and Biophysical Research Communications
Vitamin C enhances the expression of IL17 in a Jmjd2-dependent manner
Mi Hye Song, Varun Sasidharan Nair, Kwon Ik Oh · 2017 · BMB Reports
The clinical use of IDH1 and IDH2 mutations in gliomas
Alberto Pïcca, Giulia Berzero, Anna Luisa Di Stefano, Marc Sanson · 2018 · Expert Review of Molecular Diagnostics
Molecular Markers in Low-Grade Glioma—Toward Tumor Reclassification
Adriana Olar, Erik P. Sulman · 2015 · Seminars in Radiation Oncology
Emerging of lysine demethylases (KDMs): From pathophysiological insights to novel therapeutic opportunities
Sarder Arifuzzaman, Mst Reshma Khatun, Rabeya Khatun · 2020 · Biomedicine & Pharmacotherapy
Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications
Daniel M. Desaulniers, Paule Vasseur, Abigail C. Jacobs, M. Cecilia Aguila, Norman Ertych, Miriam Naomi Jacobs · 2021 · International Journal of Molecular Sciences
Clonal hematopoiesis and hematological malignancy
William G. Dunn, Matthew A. McLoughlin, George S. Vassiliou · 2024 · Journal of Clinical Investigation
KDM4B: A Nail for Every Hammer?
Cailin Beth Wilson, Adam J. Krieg · 2019 · Genes
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview
Alessandro Barbato, Grazia Scandura, Fabrizio Puglisi, Daniela Cambria, Enrico La Spina, Giuseppe A. Palumbo, Giacomo Lazzarino, Daniele Tibullo, Francesco Di Raimondo, Cesarina Giallongo et al. · 2020 · Frontiers in Oncology
Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
Yeng F. Her, Louis James Maher · 2015 · International Journal of Endocrinology
Alterations of 5-Hydroxymethylcytosine in Human Cancers
Christopher J. Mariani, Jozef Madžo, Erika L. Moen, Ali E. Yesilkanal, Lucy A. Godley · 2013 · Cancers
Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia
Paolo Gallipoli, George Giotopoulos, Brian J.P. Huntly · 2015 · Therapeutic Advances in Hematology
Metabolism-driven chromatin dynamics: Molecular principles and technological advances
Varun Sahu, Chao Lü · 2025 · Molecular Cell
Glutamate as chemotactic fuel for diffuse glioma cells: Are they glutamate suckers?
Sanne A. M. van Lith, Anna Catharina Navis, Kiek N. Verrijp, Simone P. Niclou, Rolf Bjerkvig, Pieter Wesseling, Bastiaan B.J. Tops, Remco Jurriaan Molenaar, Cornelis J.F. Van Noorden, William P. J. Leenders · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors
Magdalena Korczynska, Daniel D. Le, Noah Spector Younger, Elisabet Gregori‐Puigjané, Anthony Tumber, Tobias J. Krojer, Srikannathasan Velupillai, C. Gileadi, Radosław P. Nowak, Eriko Iwasa et al. · 2015 · Journal of Medicinal Chemistry
Introduction to Structural Studies on 2-Oxoglutarate-Dependent Oxygenases and Related Enzymes
Wei Shen Aik, Rasheduzzaman Chowdhury, Ian J. Clifton, Richard J. Hopkinson, T.M. Leissing, M.A. McDonough, Radosław P. Nowak, Christopher John Schofield, Louise J. Walport · 2015 · Royal Society of Chemistry eBooks
Mitochondrial stress causes neuronal dysfunction via an ATF4-dependent increase in L-2-hydroxyglutarate
Rachel J. Hunt, Lucy Granat, Gregory Scott McElroy, Ramya Ranganathan, Navdeep S. Chandel, Joseph M. Bateman · 2019 · The Journal of Cell Biology
The role of PHD2 mutations in the pathogenesis of erythrocytosis
Betty Gardie, Melanie J. Percy, David Hoogewijs, Rasheduzzaman Chowdhury, Celeste Bento, Mary Frances McMullin, Christopher John Schofield, Frank S. Lee, Stephane Richard, Patrick R. Arsenault et al. · 2014 · Hypoxia
Mitochondrial metabolites extend lifespan
Robert J. Mishur, Maruf H. Khan, Erin Munkácsy, Lokendra Kumar Sharma, Alex F. Bokov, Haley Beam, Oxana Radetskaya, Megan B. Borror, Rebecca K. Lane, Yidong Bai et al. · 2016 · Aging Cell
Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors
Jian Lin, Wei Lu, Justin A. Caravella, Ann Marie Campbell, R. Bruce Diebold, Anna M. Ericsson, Edward L. Fritzen, Gary R. Gustafson, David R. Lancia, Tatiana E. Shelekhin et al. · 2019 · Journal of Medicinal Chemistry
An Overview of Targeted Therapies in Acute Myeloid Leukemia
Sven Turkalj, Felix A. Radtke, Paresh Vyas · 2023 · HemaSphere
Gatekeepers of chromatin: Small metabolites elicit big changes in gene expression
Salma Kaochar, Benjamin P. Tu · 2012 · Trends in Biochemical Sciences
Novel Therapeutic Targets of Tumor Metabolism
Rigel J. Kishton, Jeffrey C. Rathmell · 2015 · The Cancer Journal
Roles of IDH1/2 and TET2 mutations in myeloid disorders
Satoshi Inoue, François Lemonnier, Tak W. Mak · 2016 · International Journal of Hematology
Inhibition of TET1 prevents the development of osteoarthritis and reveals the 5hmC landscape that orchestrates pathogenesis
Piera Smeriglio, Fiorella Carla Grandi, Spoorthi Davala, Venkata Masarapu, Pier Francesco Indelli, Stuart Barry Goodman, Nidhi Bhutani · 2020 · Science Translational Medicine
(R) -2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH -Mutant Cancers
Kathryn Gunn, Matti Myllykoski, John Z. Cao, Manna Ahmed, Bofu Huang, Betty Rouaisnel, Bill H. Diplas, Michael M. Levitt, Ryan Looper, John G. Doench et al. · 2023 · Cancer Discovery
Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma
Tania L. Slatter, Howard Hsia, Ari Samaranayaka, Peter H. Sykes, W. M. Clow, Celia J. Devenish, T. Sutton, Janice A. Royds, Philip P.C. Ip, Any Cheung et al. · 2015 · The Journal of Pathology Clinical Research
Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications
Ruta Gupta, Rebecca Webb-Myers, Simon Flanagan, Michael E. Buckland · 2011 · Journal of Clinical Pathology
Glutamine at focus: versatile roles in cancer
Humberto De Vitto, Juan Alberto Pérez-Valencia, James A. Radosevich · 2015 · Tumor Biology
Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate
Anuhar Chaturvedi, Michelle Maria Araujo Cruz, Nidhi Jyotsana, A Sharma, Ramya Goparaju, Adrian Schwarzer, Kerstin Görlich, Renate Schottmann, Eduard A. Struys, Erwin E. W. Jansen et al. · 2016 · Leukemia
Epigenetic regulators and their impact on therapy in acute myeloid leukemia
F. Pastore, R. Levine · 2016 · Haematologica
Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
Muhammad Nadeem Abbas, Saima Kausar, Hongjuan Cui · 2019 · Clinical & Translational Oncology
USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET2
Leilei Chen, Matthew D. Smith, Lei Lv, Tadashi Nakagawa, Zhijun Li, Shao‐Cong Sun, Nicholas Gene Brown, Yue Xiong, Yanping Xu · 2020 · Science Advances
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
Ling Zhang, Eric Padron, Jeffrey E. Lancet · 2014 · Leukemia Research
Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare)
David B. Liesenfeld, Nina Habermann, Réka Tóth, Robert Wyn Owen, Eva Frei, Jürgen Böhm, Petra Schrotz‐King, Karel Douglas Klika, Cornelia M. Ulrich · 2014 · Metabolomics
The Emerging Role of D-2-Hydroxyglutarate as an Oncometabolite in Hematolymphoid and Central Nervous System Neoplasms
Dinesh Rakheja, Leonard Jeffrey Medeiros, Scott Bevan, Weina Chen · 2013 · Frontiers in Oncology
Small-molecular modulators of cancer-associated epigenetic mechanisms
Yukihiro Itoh, Takayoshi Suzuki, Naoki Miyata · 2013 · Molecular BioSystems
Coordinated methyl-lysine erasure: structural and functional linkage of a Jumonji demethylase domain and a reader domain
Anup K. Upadhyay, John R. Horton, Xing Zhang, Xiaodong Cheng · 2011 · Current Opinion in Structural Biology
Epigenetic changes: a common theme in acute myelogenous leukemogenesis
Soraya Elisa Gutierrez, Francisco A Romero-Oliva · 2013 · Journal of Hematology & Oncology
Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies
Hanumantha Rao Madala, Surendra Reddy Punganuru, Viswanath Arutla, Subhasis Misra, Thresia Thomas, Kalkunte S. Srivenugopal · 2018 · Cancers
Post-translational modifications on mitochondrial metabolic enzymes in cancer
Yunhua Peng, Huadong Liu, Jiankang Liu, Jiangang Long · 2021 · Free Radical Biology and Medicine
Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
Avaniyapuram Kannan Murugan, Ahmad Alzahrani · 2022 · British Journal of Biomedical Science
ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control
Yimeng Gao, Joshua T. Zimmer, Radovan Vasic, Chengyang Liu, Rana Gbyli, Shu-Jian Zheng, Amisha J. Patel, Wei Liu, Zhihong Qi, Yaping Li et al. · 2023 · Cell Reports
Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications
Bernd Kaina · 2023 · Journal of Clinical Medicine
Metabolite regulation of epigenetics in cancer
Pu Wang, Leilei Chen, Yue Xiong, Dan Ye · 2024 · Cell Reports